CeriBell, Inc. (CBLL)
NASDAQ: CBLL · Real-Time Price · USD
16.91
+0.63 (3.87%)
Jul 24, 2026, 4:00 PM EDT - Market closed
CeriBell Revenue
CeriBell had revenue of $26.49M in the quarter ending March 31, 2026, with 29.30% growth. This brings the company's revenue in the last twelve months to $95.07M, up 32.89% year-over-year. In the year 2025, CeriBell had annual revenue of $89.06M with 36.09% growth.
Revenue (ttm)
$95.07M
Revenue Growth
+32.89%
P/S Ratio
6.75
Revenue / Employee
$290,722
Employees
327
Market Cap
641.61M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 89.06M | 23.62M | 36.09% |
| Dec 31, 2024 | 65.44M | 20.22M | 44.71% |
| Dec 31, 2023 | 45.23M | 19.30M | 74.47% |
| Dec 31, 2022 | 25.92M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCBLL News
- 4 days ago - Ceribell to Report Second Quarter 2026 Financial Results on August 10, 2026 - GlobeNewsWire
- 26 days ago - CeriBell Slides: Corporate presentation - Filings
- 6 weeks ago - Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes - GlobeNewsWire
- 7 weeks ago - CeriBell Transcript: 46th Annual William Blair Growth Stock Conference - Transcripts
- 7 weeks ago - CeriBell Transcript: AGM 2026 - Transcripts
- 2 months ago - Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference - GlobeNewsWire
- 2 months ago - CeriBell Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Ceribell price target lowered to $25 from $28 at Canaccord - TheFly